PubMed HealthSearch

Biomedical subjects

A L Hunter

Publications and source records attributed to A L Hunter.

10 recordsLinked to original sources

Female social reproductive roles affect central monoamines.

Central monoamines display a variety of activation patterns in different social groups, and among males and females. We addressed three social conditions for female lizards of the species Anolis carolinensis: Isolated, paired with a mate, and in a group of 5 competing for one mate. Among those in a group, only 1 or 2 females exhibited recrudescing ovaries. Individuals paired with a mate (for one month) exhibited ovarian growth, isolated animals (initial controls) had quiescent ovaries. Reproductively dominant females had significantly greater telencephalic 5-HIAA, and serotonergic activation, as indicated by the ratio of 5-HIAA to 5-HT. Telencephalic HVA as well as the HVA/DA ratio were also significantly greater in dominant females compared to all other groups. In contrast, serotonergic activation in brainstem was elevated in subordinate females only. These results suggest that serotonergic activation in telencephalon, found only in dominant females, not in other reproductively active females, is a function of the unique social role of a dominant female, possibly combining submissive behaviors toward a male with dominance over other females and competition for access to that male. Dopaminergic activation in telencephalon, also found only in dominant females, may be related to aggressive interactions with other females. Activation of serotonin in brainstem, found in this study in subordinate females and previously in males [C.H. Summers and N. Greenberg, Activation of central biogenic amines following aggressive interaction in male lizards, Anolis carolinensis, Brain Behav. Evol., 45 (1995) 339-349], may be associated with subordinate social status. Monoamines, involved in social behaviors, appear to be regionally specialized for dominant and subordinate social roles, in males [C.H. Summers and N. Greenberg, Activation of central biogenic amines following aggressive interaction in male lizards, Anolis carolinensis, Brain Behav. Evol., 45 (1995) 339-349][T.R. Summers, E.T. Larson, A.L. Hunter, K.J. Renner, N. Greenberg and C.H. Summers, Amygdalar serotonin mediates long-term social roles following aggressive interaction, Soc. Neurosci. Abs., 22 (1996) 1147] and females. Dominant females exhibit unique social position, behavior and monoamine profile whereas subordinate females and males have a similar serotonergic response in this species.

Aggression

Conversion of N-(2-chloroethyl)-4-piperidinyl diphenylacetate (4-DAMP mustard) to an aziridinium ion and its interaction with muscarinic receptors in various tissues.

A 2-chloroethylamine derivative [N-(2-chloroethyl)-4-piperidinyl diphenylacetate (4-DAMP mustard)] of the selective muscarinic antagonist N,N-dimethyl-4-piperidinyl diphenylacetate (4-DAMP) was synthesized, and its conversion to an aziridinium ion and interaction with muscarinic receptors was investigated. When dissolved in aqueous solution at pH 7.4 and 37 degrees, 4-DAMP mustard released an equivalent amount of chloride. The release of chloride was consistent with a first-order process having a half-time of 5.7 min. The aziridinium ion reached a peak concentration at 32 min, corresponding to 75% of the initial concentration of 4-DAMP mustard. When homogenates of rat brain, heart, and submaxillary gland were incubated with 4-DAMP mustard (9 nM) for 1 hr, washed extensively, and then assayed for muscarinic receptor binding properties, a 56% decrease in the binding capacity of N-[3H]methylscopolamine in the heart and brain and a 71% decrease in the gland were observed, without a significant change in the dissociation constants. The affinity of 4-DAMP mustard and its transformation products for muscarinic receptors was determined in competitive binding experiments with N-[3H] methylscopolamine, and the results show that the aziridinium ion of 4-DAMP mustard was the most potent form, compared with the parent 2-chloroethylamine (4-DAMP mustard) and the alcoholic hydrolysis product. The rates of receptor alkylation by 4-DAMP mustard were measured in the rat heart and gland. Virtually no alkylation (less than 1%) occurred in the heart at a 4-DAMP mustard concentration of 1.6 nM, after 30 min, whereas almost 50% alkylation was observed in the gland under the same conditions. Almost complete alkylation of receptors in the gland could be achieved at a 4-DAMP mustard concentration of 200 nM, after 1 hr. Treatment of the isolated rat ileum with 4-DAMP mustard caused an irreversible blockade of contractions elicited by the muscarinic agonist oxotremorine-M, and this blockade persisted after extensive washing. The results presented here show that 4-DAMP mustard forms an aziridinium ion that binds irreversibly to muscarinic receptors and exhibits selectivity for M3, compared with M2 muscarinic receptors.

Alkylation

Gluten antibodies in patients with multiple sclerosis.

The level of gluten antibodies has been determined in plasma samples from 36 patients with MS using a haemagglutination technique. Only one of the 36 patients studied showed any evidence of gluten antibodies and the level of antibodies in this patient did not justify putting the patient on a gluten-free diet. This study has provided no evidence to support the use of a gluten-free diet as part of the management of MS.

Adult

Thioacetamide-induced hepatic necrosis. I. Involvement of the mixed-function oxidase enzyme system.

Metabolic activation of thioacetamide (CH3CSNH2) to a toxic metabolite which is responsible for its hepatotoxicity and/or its carcinogenicity has been proposed by a number of investigators. In this investigation thioacetamide and one of its metabolites, thioacetamide sulfine (CH3CSONH2), have been compared for their ability to inhibit hepatic mixed-function oxidase enzymes as well as their ability to induce hepatic necrosis. Thioacetamide sulfine was found to decrease aminopyrine N-demethylation and aniline hydroxylation at a lower dose and at an earlier time after administration than was the case with thioacetamide. In addition, at all doses examined, thioacetamide sulfine produced a more severe centrilobular hepatic necrosis than equivalent doses of thioacetamide. To determine whether the hepatic mixed-function oxidase enzyme system was involved in the biotransformation of thioacetamide and/or thioacetamide sulfine to a hepatotoxic compound(s), the severity of liver damage was examined after the administration of an inducer or inhibitors of hepatic mixed-function oxidase enzyme activity. Phenobarbital pretreatment potentiated the hepatic necrosis produced by both thioacetamide and thioacetamide sulfine. In contrast, pyrazole, SKF 525-A, and cobaltous chloride protected against the hepatic necrosis caused by thioacetamide and thioacetamide sulfine. These data suggest that both thioacetamide and thioacetamide sulfine are activated by hepatic mixed-function oxidase enzymes to a hepatotoxic compound(s). These data also suggest that the hepatotoxicity may be mediated by its metabolism to thioacetamide sulfine which, in turn, is metabolized to an ultimate toxic metabolite.

Acetamides

Biliary excretion of colchicine.

After intravenous administration of 3H-colchicine (0.2 mg/kg) to rats, 68 percent was excreted in the feces in 48 hours suggesting bile might be the major route of excretion for colchicine. Rats with cannulated bile ducts excreted 50 percent of a 2 mg/kg dose into the bile within 2 hours; half of this was colchicine, and the rest was desmethylcolchicine and more polar metabolites. Colchicine was excreted into the bile of the rat against a bile/plasma concentration gradient of 800 which resulted from a liver/plasma ratio of 15 and a bile/liver ratio of 60. The biliary excretion of colchicine varied widely among the hamster, dog and rabbit. Of the administered colchicine, 32, 20 and 16 percent were excreted by the hamster, dog and rabbit, respectively, within 2 hours. There was also a species difference in the percentage of the radioactivity present in bile as the parent drug. In the hamster, dog and rabbit, the percentage of radioactivity excreted into the bile as colchicine was 45, 34 and 72 percent, respectively. These species excreted colchicine into the bile against a bile/plasma gradient ranging from 19 to 870. Partition of these gradients between liver/plasma and bile/liver ratios demonstrated that both ratios were greater than one, suggesting that colchicine is excreted by an active process. The liver/bile gradient was always the larger of the two ratios.

Animals

Biliary excretion of colchicine in newborn rats.

The 24-hr LD50 of colchicine in newborn rats is 0.24 mg/kg, which is about 1/10 that observed in the adult. The 24-hr LD50 of colchicine was relatively constant in rats over 25 days of age. In an attempt to determine the mechanism of the increased sensitivity of the newborn rat to the toxic action of colchicine, the distribution of 3H after the administration of 3H-colchicine (0.1 mg/kg) was measured in 10- and 35-day-old rats. The concentration of 3H was higher in all tissues of the newborn than the adult after ip administration, suggesting an immaturity in the pathway for colchicine elimination. After iv administration, radioactivity disappeared much more slowly from the plasma of the newborn rat than from the adult. This was due to a lower capacity of the liver of the newborn to concentrate colchicine and to excrete it into the bile. Development of the hepatic excretory mechanism responsible for excretion of colchicine occurred at the same age as did the increase in LD50. These results suggest that colchicine is more toxic in the newborn because the drug remains in the body for a longer time due to immaturity of the liver excretory process.

Age Factors